Aug 2026· Translational Oncology· Vol 72· 0 citations· 32 references
Medicine
TL;DR
Ageing-gene network perturbation defines three colorectal cancer subtypes and silencing MAP1B curbs invasion and migration and shrinks mouse tumors.
Abstract
Highlights • Aging-gene network perturbation defines three colorectal cancer subtypes.• Stromal-invasive and lipid-driven subtypes fare worse than the proliferative one.• MAP1B ranks first across six cohorts and rises with stage and metastasis.• Silencing MAP1B curbs invasion and migration and shrinks mouse tumors.• MAP1B-high tumors favor dasatinib, which adds to the effect of MAP1B loss.
Highlights • The CRSS model effectively stratifies BLCA patients into high- and low-risk groups and predicts bladder cancer survival.• CRSS reveals immune infiltration patterns and therapy sensitivity.• Machine learning combined with Mendelian randomization identifies key CRGs.• SPHK1 drives proliferation and migration...
Chengyuan Dong, Zhou Fang, Yiling Han et al.· Translational Oncology· 0 citations
Single-cell sequencing reveals resistance-linked malignant subcluster in LUAD, confirming oncogenic role and CoxBoost + survivalSVM model achieves optimal C-index of 0.686 across seven cohorts.
Z. Qiu, Hui Zhao, Qiong Lyu et al.· Translational Oncology· 0 citations
Single-cell analysis identifies M8 fibroblast subcluster as dominant post-NACT population linked to ovarian cancer chemo-resistance and NHP2 knockdown suppresses proliferation, migration and invasion of ovarian cancer cells in vitro.
Mingqin Kuang, Chang-Mei Shen, Chun-Ping Yang et al.· Translational Oncology· 0 citations
High-resolution mapping of 52,384 cells uncovers hierarchical intra-tumor heterogeneity in HCC and TMEM176B is identified as the link between tumor malignancy hierarchy and immune remodeling.
Hong Chen, Jian-Feng Gong, De-Ying He et al.· Translational Oncology· 0 citations
It was revealed that cells with high LIM scores were predominantly fibroblasts, and Erlotinib, fulvestrant, EPZ5676, and AZD1208 were identified as potential therapeutic agents for patients in the low-LIMRS group, whereas vinblastine, docetaxel, paclitaxel, and vinorelbine may be more suitable for high-LIMRS group pati...
Xin-Yu Zhao, Yili Shao, Huang Huang et al.· Translational Oncology· 0 citations
This study systematically investigated the RGS family to identify potential biomarkers and therapeutic targets in breast cancer and identified potential biomarkers and therapeutic targets that improve prognosis in subsets of patients.
Zohreh Mirzaei, Madiheh Mazaheri Moghaddam, Tahereh Barati et al.· Cancer Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.